{"id":"W2563483539","doi":"10.1182/blood.v106.11.2547.2547","title":"Bortezomib Continues Demonstrates Superior Efficacy Compared with High-Dose Dexamethasone in Relapsed Multiple Myeloma: Updated Results of the APEX Trail.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; Dexamethasone; Internal medicine; Clinical endpoint; Adverse effect; Progressive disease; Surgery; Refractory (planetary science); Gastroenterology; Clinical trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003360803,0.0005246399,0.001432543,0.0002318128,0.000222446,0.001410585,0.000558295,0.0006661643,0.004766306],"category_scores_gemma":[0.003087689,0.0002618029,0.001315318,0.0006735996,0.0003938231,0.0006695151,0.0003501482,0.002053863,0.0005370803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005365299,"about_ca_system_score_gemma":0.0008743681,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006088719,"about_ca_topic_score_gemma":0.002271158,"domain_scores_codex":[0.9991122,0.0004835025,0.00009401663,0.00008506746,0.0001374029,0.00008786762],"domain_scores_gemma":[0.9968911,0.001097284,0.001123831,0.0003051854,0.0001925325,0.0003901408],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7386858,0.004337391,0.01727731,0.002283157,0.005579132,0.0001548885,0.0002616958,0.00147216,0.008115135,0.0005977072,0.0193079,0.2019278],"study_design_scores_gemma":[0.6902505,0.176123,0.07935691,0.0006785365,0.009189437,0.000776791,0.0001913986,0.001788988,0.005587793,0.001140952,0.03482463,0.00009115259],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9280151,0.05044202,0.0006780285,0.002039218,0.0006932359,0.0006516421,0.008378954,0.0001581138,0.008943757],"genre_scores_gemma":[0.9739335,0.009538283,0.00118391,0.001906764,0.0006085075,0.0004269431,0.009335246,0.00004480505,0.003022032],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004766306,"threshold_uncertainty_score":0.01777387,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01994381614783158,"score_gpt":0.2671768286086359,"score_spread":0.2472330124608043,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}